The aim is to explore the IL-23/IL-17/NF-κB signaling pathway and its role in rheumatoid arthritis.
Review of molecular mechanisms involved in the signaling pathway.
Examination of therapeutic agents targeting these pathways.
Analysis of their effects on rheumatoid arthritis.
Identified key molecular mechanisms associated with rheumatoid arthritis progression.
Discussed potential therapeutic agents targeting the IL-23/IL-17/NF-κB pathway.
Highlighted implications for future treatments and patient outcomes.
Abstract
The cover image is based on The IL-23/IL-17/NF-κB Signaling Pathway in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Agents by Jiayi Deng et al., https://doi.org/10.1002/med.70024.